Abstract
Purpose
To study the effect of topical bimatoprost on the corneal optical density values using a dual Scheimpflug Placido analysis system.
Methods
This longitudinal case–control study included 18 patients with newly diagnosed primary open-angle glaucoma who received topical bimatoprost as a first-line treatment and 20 healthy individuals (age and sex-matched controls). Corneal densitometry data were obtained using the dual Scheimpflug analyzer at pre-treatment and 1st, 6th, 12th, 18th months of post-treatment. Repeated measures of ANOVA and Pearson correlation tests were used for statistical analysis.
Results
There were statistically significant differences between pre-treatment and post-treatment 1st and 6th months corneal densitometry values (p < 0.001, p = 0.007, respectively). However, there was no statistically significant difference between the post-treatment 12th and 18th months (p > 0.05). Corneal densitometry values decreased during the 1st month. Intraocular pressure (IOP) differences were statistically significant between baseline and 1 month after treatment (P < 0.001), however not statistically significant between the 1st and 6th, 6th and 12th, 12th and 18th months after treatment (p > 0.05, for all). Corneal densitometry was not correlated with IOP (r = − 0.037, p = 0.44). In the control group, there was no statistically significant difference between baseline and post-baseline 18th-month corneal densitometry measurements (p > 0.05).
Conclusions
Topical bimatoprost administration might result in a decrease in corneal densitometry measurement. It is of clinical importance that topical bimatoprost administration can affect corneal transparency and cause a possible alteration in corneal properties.
Similar content being viewed by others
References
Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Opthalmol 90(3):262–267
Tham Y-C, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Opthalmology 121(11):2081–2090
Weinreb RN, Robinson MR, Dibas M et al (2020) Matrix metalloproteinases and glaucoma treatment. J Ocul Pharmacol Ther 36(4):208–228
Lee AJ, McCluskey P (2010) Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Opthalmol 4:741
Park MH, Cho K, Moon JI (2009) The effects of prostaglandin analogues on the corneal thickness. J Korean Ophthalmol Soc 50:565–571
Toris CB, B’Ann TG, Kaufman PL (2008) Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Opthalmol 53:S107–S120
Savini G, Carbonelli M, Barboni P et al (2011) Repeatability of automatic measurements performed by a dual Scheimpflug analyzer in unoperated and post-refractive surgery eyes. J Cataract Refract Surg 37(2):302–309
Group CZ (2020) Product Specs; GALILEI™ Dual Scheimpflug Analyzer. v. 2020
Otri AM, Fares U, Al-Aqaba MA, Dua HS (2012) Corneal densitometry as an indicator of corneal health. Opthalmology 119(3):501–508
Shen Y, Han T, Jhanji V et al (2019) Correlation between corneal topographic, densitometry and biomechanical parameters in keratoconus eyes. Transl Vis Sci Technol 8(3):12
Alnawaiseh M, Zumhagen L, Zumhagen S et al (2016) Corneal densitometry as a novel technique for monitoring amiodarone therapy. Opthalmology 123(11):2294–2299
Blanco A, Bagnasco L, Bagnis A et al (2017) European Glaucoma Society Terminology and Guidelines for Glaucoma, —Chapter 2: classification and terminology supported by the EGS Foundation: Part 1: foreword; introduction; glossary; Chapter 2 classification and terminology. 101:73–127
Dhubhghaill SN, Rozema JJ, Jongenelen S et al (2014) Normative values for corneal densitometry analysis by scheimpflug optical assessment. Invest Opthalmol Vis Sci 55(1):162–168
Doucette LP, Walter MA (2017) Prostaglandins in the eye: function, expression, and roles in glaucoma. Opthalmic Genet 38(2):108–116
Brubaker RF (2001) Mechanism of action of bimatoprost (Lumgian™). Surv Opthalmol 45:S347–S351
Stewart WC, Konstas AG, Nelson LA, Kruft B (2008) Meta-analysis of 24-h intraocular pressure studies evaluating the efficacy of glaucoma medicines. Opthalmology 115(7):1117–1122
Dubiner H, Cooke D, Dirks M et al (2001) Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Opthalmol 45:S353–S360
Gandolfi S, Simmons ST, Sturm R et al (2001) Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther 18(3):110–121
Walters TR, DuBiner HB, Carpenter SP et al (2004) 24-h IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial. Surv Opthalmol 49(2):S26-35
Noecker RS, Dirks MS, Choplin NT et al (2003) A 6-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Opthalmol 135(1):55–63
Zhong Y, Shen X, Yu J et al (2011) The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness. Cornea 30(8):861–864
Arcieri E, Pierre Filho P, Wakamatsu T, Costa VJE (2008) The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension. Eye (Lond) 22(2):179–183
Hatanaka M, Vessani RM, Elias IR et al (2009) The effect of prostaglandin analogs and prostamide on central corneal thickness. J Ocul Pharmacol Ther 25(1):51–54
Bafa M, Georgopoulos G, Mihas C et al (2011) The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes. Acta Opthalmol 89(5):448–451
Korey M, Gieser D, Kass MA et al (1982) Central corneal endothelial cell density and central corneal thickness in ocular hypertension and primary open-angle glaucoma. Am J Opthalmol 94(5):610–616
Iester M, Telani S, Brusini P et al (2013) Central corneal thickness and glaucoma treatment: an Italian multicenter cross-sectional study. J Ocul Pharmacol Ther 29(5):469–473
Wan Z, Woodward DF, Cornell CL et al (2007) Bimatoprost, prostamide activity, and conventional drainage. Invest Opthalmol Vis Sci 48(9):4107–4115
Sen E, Inanc M, Elgin U (2019) The effect of topical latanoprost on corneal clarity; 1-year prospective study. Cutan Ocul Toxicol 38(3):253–257
Bergonzi C, Giani A, Blini M et al (2010) Evaluation of prostaglandin analogue effects on corneal keratocyte density using scanning laser confocal microscopy. J Glaucoma 19(9):617–621
Wu N, Chen Y, Yu X et al (2016) Changes in corneal biomechanical properties after long-term topical prostaglandin therapy. PLoS One 11(5):e0155527
Nakagawa S, Usui T, Yokoo S et al (2012) Toxicity evoluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets. Invest Opthalmol Vis Sci 53:5154–8180
Wensheng C, Nuo D, Caihong H et al (2014) Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit. PLoS One 9(3):e89205
Huang J, Ding X, Savini G et al (2014) Central and midperipheral corneal thickness measured with Scheimpflug imaging and optical coherence tomography. PLoS One 9(5):e98316
Rafii AB, Motevasseli T, Yazdizadeh F et al (2017) Comparision between two Scheimpflug anterior segment analyzers. J Ophthalmic Vis Res 12(1):23–29
Funding
No external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflict of Interest. The authors indicate no financial support or financial conflict of interest. The authors have indicated they have no financial relationships with any company
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Eraslan, N., Ekici, E. & Celikay, O. The effect of topical bimatoprost on corneal clarity in primary open-angle glaucoma: a longitudinal prospective assessment. Int Ophthalmol 42, 731–738 (2022). https://doi.org/10.1007/s10792-021-02035-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-021-02035-1